{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:19:44Z","timestamp":1741839584245,"version":"3.38.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tumors of Urinary System treatment in China","award":["020"],"award-info":[{"award-number":["020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93728-5","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:16:47Z","timestamp":1741792607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ABO blood group system correlates with preoperative serum PSA level in patients with prostate cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Fangming","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianzeng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"93728_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren, O. et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur. Urol. 84, 191\u2013206 (2023).","journal-title":"Eur. Urol."},{"key":"93728_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp, M. B. et al. Recent global patterns in prostate cancer incidence and mortality rates. Eur. Urol. 77, 38\u201352 (2020).","journal-title":"Eur. Urol."},{"key":"93728_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update part 1: Screening, diagnosis, and local treatment with curative intent. Eur. Urol. 79, 243\u2013262 (2021).","journal-title":"Eur. Urol."},{"key":"93728_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41585-020-0287-y","volume":"17","author":"AJ Costello","year":"2020","unstructured":"Costello, A. J. Considering the role of radical prostatectomy in 21st century prostate cancer care. Nat. Rev. Urol. 17, 177\u2013188 (2020).","journal-title":"Nat. Rev. Urol."},{"key":"93728_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/cid\/ciaa1150","volume":"73","author":"J Zhao","year":"2021","unstructured":"Zhao, J. et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin. Infect. Dis. 73, 328\u2013331 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"93728_CR6","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1182\/blood.2020005843","volume":"136","author":"SE Ward","year":"2020","unstructured":"Ward, S. E., O\u2019Sullivan, J. M. & O\u2019Donnell, J. S. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis. Blood 136, 2864\u20132874 (2020).","journal-title":"Blood"},{"key":"93728_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10408363.2012.708647","volume":"49","author":"M Franchini","year":"2012","unstructured":"Franchini, M., Favaloro, E. J., Targher, G. & Lippi, G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit. Rev. Clin. Lab. Sci. 49, 137\u2013149 (2012).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"93728_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ijc.34533","volume":"153","author":"H Cui","year":"2023","unstructured":"Cui, H. et al. Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer. Int. J. Cancer. 153, 320\u2013330 (2023).","journal-title":"Int. J. Cancer."},{"key":"93728_CR9","first-page":"1321","volume":"16","author":"D Staki\u0161aitis","year":"2018","unstructured":"Staki\u0161aitis, D. et al. ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. Oncol. Lett. 16, 1321\u20131331 (2018).","journal-title":"Oncol. Lett."},{"key":"93728_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11701-021-01267-8","volume":"16","author":"AB Porcaro","year":"2022","unstructured":"Porcaro, A. B. et al. ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: Results in 1114 consecutive patients. J. Robot Surg. 16, 507\u2013516 (2022).","journal-title":"J. Robot Surg."},{"key":"93728_CR11","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/pros.23035","volume":"75","author":"SC Markt","year":"2015","unstructured":"Markt, S. C. et al. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3). Prostate 75, 1677\u20131681 (2015).","journal-title":"Prostate"},{"key":"93728_CR12","doi-asserted-by":"publisher","first-page":"9237481","DOI":"10.1155\/2017\/9237481","volume":"2017","author":"FM Wang","year":"2017","unstructured":"Wang, F. M. et al. Association of ABO blood types and clinicopathological features of prostate cancer. Dis. Markers 2017, 9237481 (2017).","journal-title":"Dis. Markers"},{"key":"93728_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.906936","volume":"12","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. Preoperative platelet count correlates with postoperative perineural invasion on specimen in patients treated with radical prostatectomy. Front. Oncol. 12, 906936 (2022).","journal-title":"Front. Oncol."},{"key":"93728_CR14","doi-asserted-by":"publisher","first-page":"1020655","DOI":"10.3389\/fendo.2022.1020655","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. Preoperative red cell distribution width is associated with postoperative lymphovascular invasion in prostate cancer patients treated with radical prostatectomy: A retrospective study. Front. Endocrinol. (Lausanne) 13, 1020655 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"93728_CR15","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1021\/acssensors.3c01402","volume":"8","author":"S Garg","year":"2023","unstructured":"Garg, S. et al. Point-of-care prostate specific antigen testing: Examining translational progress toward clinical implementation. ACS Sens. 8, 3643\u20133658 (2023).","journal-title":"ACS Sens."},{"key":"93728_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.53.082901.104000","volume":"53","author":"EI Canto","year":"2002","unstructured":"Canto, E. I. & Slawin, K. M. Early management of prostate cancer: How to respond to an elevated PSA?. Annu. Rev. Med. 53, 355\u2013368 (2002).","journal-title":"Annu. Rev. Med."},{"key":"93728_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.eururo.2005.04.015","volume":"48","author":"AW Roddam","year":"2005","unstructured":"Roddam, A. W. et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2\u201310 ng\/ml: Systematic review and meta-analysis. Eur. Urol. 48, 386\u2013399 (2005).","journal-title":"Eur. Urol."},{"key":"93728_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/trf.15760","volume":"60","author":"Y Kominato","year":"2020","unstructured":"Kominato, Y. et al. Human ABO gene transcriptional regulation. Transfusion 60, 860\u2013869 (2020).","journal-title":"Transfusion"},{"key":"93728_CR19","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.ejca.2010.08.009","volume":"46","author":"S Iodice","year":"2010","unstructured":"Iodice, S. et al. ABO blood group and cancer. Eur. J. Cancer 46, 3345\u20133350 (2010).","journal-title":"Eur. J. Cancer"},{"key":"93728_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1158\/0008-5472.CAN-09-2993","volume":"70","author":"BM Wolpin","year":"2010","unstructured":"Wolpin, B. M. et al. Pancreatic cancer risk and ABO blood group alleles: Results from the pancreatic cancer cohort consortium. Cancer Res. 70, 1015\u20131023 (2010).","journal-title":"Cancer Res."},{"key":"93728_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/jnci\/djq007","volume":"102","author":"HA Risch","year":"2010","unstructured":"Risch, H. A. et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: A case-control study. J. Natl. Cancer Inst. 102, 502\u2013505 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"93728_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.canep.2012.07.001","volume":"36","author":"HK Joh","year":"2012","unstructured":"Joh, H. K., Cho, E. & Choueiri, T. K. ABO blood group and risk of renal cell cancer. Cancer Epidemiol. 36, 528\u2013532 (2012).","journal-title":"Cancer Epidemiol."},{"key":"93728_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ijc.25339","volume":"128","author":"MA Gates","year":"2011","unstructured":"Gates, M. A. et al. ABO blood group and incidence of epithelial ovarian cancer. Int. J. Cancer 128, 482\u2013486 (2011).","journal-title":"Int. J. Cancer"},{"key":"93728_CR24","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00345-015-1531-6","volume":"33","author":"O Engel","year":"2015","unstructured":"Engel, O. et al. The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. World J. Urol. 33, 1769\u20131776 (2015).","journal-title":"World J. Urol."},{"key":"93728_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4081\/aiua.2022.4.428","volume":"94","author":"A Tafuri","year":"2022","unstructured":"Tafuri, A. et al. AB0 blood groups and oncological and functional outcomes in bladder cancer patients treated with radical cystectomy. Arch. Ital. Urol. Androl. 94, 428\u2013433 (2022).","journal-title":"Arch. Ital. Urol. Androl."},{"key":"93728_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10568","volume":"8","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. Distribution characteristics of ABO blood groups in China. Heliyon 8, e10568 (2022).","journal-title":"Heliyon"},{"key":"93728_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/bcr302","volume":"3","author":"F Mannello","year":"2001","unstructured":"Mannello, F. & Gazzanelli, G. Prostate-specific antigen (PSA\/hK3): A further player in the field of breast cancer diagnostics?. Breast Cancer Res. 3, 238\u2013243 (2001).","journal-title":"Breast Cancer Res."},{"key":"93728_CR28","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/sj.bjc.6690254","volume":"79","author":"S Majumdar","year":"1999","unstructured":"Majumdar, S. & Diamandis, E. P. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines. Br. J. Cancer 79, 1594\u20131602 (1999).","journal-title":"Br. J. Cancer"},{"key":"93728_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00006842-199209000-00008","volume":"54","author":"JK Neumann","year":"1992","unstructured":"Neumann, J. K. et al. Effects of stress and blood type on cortisol and VLDL toxicity preventing activity. Psychosom. Med. 54, 612\u2013619 (1992).","journal-title":"Psychosom. Med."},{"key":"93728_CR30","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D'Amico","year":"1998","unstructured":"D\u2019Amico, A. V. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280, 969\u2013974 (1998).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93728-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93728-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93728-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:16:49Z","timestamp":1741792609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93728-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93728"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93728-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving humans were reviewed and approved by the Ethical Committees of Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital and National Cancer Center. The studies were conducted in accordance with the local legislation and institutional requirements. Due to the retrospective nature of the study, the Ethical Committees of Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital waived the need of obtaining informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"8586"}}